Table of Contents
The complete guide to choosing a policy that actually pays when you need it to
Health insurance is arguably the most-purchased and least-understood financial product in urban India today. Nearly every salaried household, every retiree, and every family with ageing parents holds at least one policy — yet survey after survey and regulator disclosure after regulator disclosure show that most policyholders cannot correctly explain their own room rent limit, their waiting period, or the difference between a claim that was “settled” and a claim that was actually paid in full. That gap between owning a policy and understanding one is where mis-selling, disappointment, and financial hardship at the worst possible moment all live.
This guide works through the Indian health insurance landscape end to end: what the products actually are, the jargon insurers rely on you not reading closely, the genuinely large regulatory reset of 2024–2026, how mis-selling happens mechanically (not just anecdotally), what changes as buying shifts online, and a concrete framework for choosing and holding the right policy — including the specific considerations for senior citizens and for NRIs managing cover for themselves or their parents from abroad. Every figure and rule below is checked against IRDAI circulars, the IRDAI Annual Report 2024–25, GST Council notifications, and National Health Authority data current to date of writing.
₹1,27,417 Cr
Total health insurance premium collected in India, FY2024–25 — up 9.2% year-on-year (IRDAI)
0% GST
On individual health premiums since 22 Sept 2025, down from 18% (56th GST Council)
60 months
New moratorium after which most claims can no longer be contested — down from 96 months
12–14%
Annual medical inflation in India, roughly 3x general consumer inflation (industry surveys)
01 Why Health Insurance Matters More Than Ever
India’s demographic and cost curves are moving in a direction that makes health insurance less of an optional financial product and more of a structural necessity. Three trends are converging.
An affluent population that is also ageing
India’s over-60 population is growing faster than the population as a whole, and a meaningfully larger share of it now has the income, savings, and urban-hospital access that earlier generations of Indian retirees did not. That combination — more years lived, more disposable wealth, and greater exposure to expensive private tertiary care — is exactly the profile for which health insurance delivers the most value and where mis-selling does the most damage, because seniors are simultaneously the costliest customers to insure and the customers most targeted by agents chasing commission on a sale rather than a fit.
Medical costs are rising nearly three times faster than general inflation
Industry medical-trend surveys put Indian healthcare cost inflation at roughly 12–14% a year through 2025, easing only slightly to about 11.5% projected for 2026 — a rate consistently cited as among the highest in Asia and roughly three times India’s general consumer inflation. This is a private-treatment-cost trend figure from insurer and employer claims data, not the official CPI health sub-index (which tracks a narrower, more regulated basket and reads far lower); both are real, but they measure different things, and confusing them is one reason people underestimate how fast their cover needs to grow. A hospitalisation that costs ₹5 lakh today can plausibly cost close to ₹18–19 lakh in a decade at a sustained 14% trend — which is the single strongest argument for topping up an old, static sum insured rather than assuming a policy bought years ago is still adequate.
Government cover has genuinely expanded — but has real limits
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) has been India’s flagship public health cover since 2018, offering eligible economically weaker families up to ₹5 lakh per family per year at empanelled hospitals. In October 2024 the government extended a parallel benefit — the Ayushman Vay Vandana Yojana — to every Indian citizen aged 70 and above, with no income test at all: a further ₹5 lakh a year in cashless cover, on top of any existing family PM-JAY cover, purely on the basis of age, with no PED waiting period at all — coverage starts from day one, including pre-existing conditions. Enrolment has scaled quickly: from roughly 86 lakh cards a year after launch to over 1.14 crore by end-February 2026, per the Ministry of Health’s own written reply to the Rajya Sabha — against an estimated eligible base of around 6 crore, so meaningful headroom for further enrolment remains. This is genuinely useful, and every affluent family with a parent turning 70 should register for it regardless of what private cover the parent already holds, since it costs nothing, carries no waiting period, and stacks with private insurance. But it is not a substitute for private cover for an affluent family: the empanelled-hospital network under PM-JAY skews toward government and mid-tier private facilities rather than the premium tertiary hospitals many urban families prefer, and ₹5 lakh does not go far against a metro cardiac or oncology bill. Treat it as a floor, not a plan.
02 The Product Landscape: What You're Actually Choosing Between
“Health insurance” in India is not one product but a family of structurally different ones, and a large share of dissatisfaction traces back to buying the wrong shape of product for the situation rather than a bad insurer.
| Product type | What it actually does | Best suited to |
|---|---|---|
| Individual indemnity policy | Covers one person; sum insured is theirs alone | Single earners, or where floater pricing doesn't suit the family's age spread |
| Family floater | One shared sum insured across the family; cheaper per head while everyone is healthy | Young families with similar risk profiles — loses efficiency once one member is much older or has PEDs |
| Senior citizen policy | Underwritten for the 60+/65+ segment; often carries mandatory co-pay and shorter but present PED waiting periods | Parents or self, post-retirement, where a standard retail plan's underwriting would decline or heavily load |
| Base sum insured + super top-up | A modest base policy plus a much larger top-up that activates after a deductible is crossed | Cost-efficient way to reach a large effective sum insured without paying full premium on the whole amount |
| Critical illness (benefit-based) | Pays a lump sum on diagnosis of a listed condition, regardless of actual treatment cost | Layered on top of indemnity cover to fund income loss, non-medical costs, or a second opinion abroad |
| Group / corporate policy | Employer-provided, usually broader underwriting, ends at employment | Should never be a family's only cover — it disappears at resignation, retirement or layoff, often exactly when age makes buying fresh cover hardest |
| Standard products (e.g. Arogya Sanjeevani) | IRDAI-mandated identical wording and benefits across every insurer that offers it | First-time buyers who want to compare price alone, since the policy terms are standardised by regulation |
Two structural points are worth internalising before comparing specific policies. First, a family floater’s price advantage erodes as the age gap in the family widens — insuring a 68-year-old parent and a 12-year-old child under one floater sum insured usually costs more, and covers each of them worse, than a modest floater for the younger members plus a dedicated senior policy for the parent. Second, the base-policy-plus-super-top-up structure is not a lesser product; used correctly it is the most capital-efficient way for a middle-income family to reach a ₹25–50 lakh effective sum insured, because a super top-up’s per-lakh premium above the deductible is materially cheaper than extending a single large base policy to the same amount. The trade-off is that the deductible must genuinely be crossed for the top-up to pay — which is why insurers increasingly offer top-ups that aggregate multiple hospitalisations in a year toward the deductible, rather than resetting it per claim; check which type you’re being sold.
03 Decoding the Jargon: The Clauses That Decide What You Actually Get Paid
Almost every disappointing claim outcome traces back to one of the terms below being misunderstood at the point of purchase rather than at the point of hospitalisation, when it is too late to do anything about it.
| Term | What it means for your payout |
|---|---|
| Sum insured | The maximum the policy will pay in a policy year. Not adjusted automatically for medical inflation — a static ₹5 lakh cover bought a decade ago buys roughly a third of the treatment it once did. |
| Deductible | A fixed amount you bear before the policy (typically a top-up) starts paying. Distinct from a co-pay, which is a percentage, not a fixed sum. |
| Co-pay | A fixed percentage of every claim that you pay regardless of amount. Very common on senior-citizen policies (commonly 10–30%) and on policies bought without medical tests — read for this specifically, since it silently shrinks every single payout, not just large ones. |
| Room rent limit and proportionate deduction | A daily cap on the room category the policy pays for. Under the IRDAI Master Circular of 29 May 2024, if you exceed the cap, the proportionate cut now applies only to room-linked charges — room rent, doctor visits tied to room category, nursing — and no longer to ICU charges, medicines, implants, diagnostics or consumables, which must be paid in full regardless of room choice. Sub-limits themselves were not banned by this circular; they remain a permitted, and still common, design feature that must be clearly disclosed. |
| Pre-existing disease (PED) waiting period | The time you must hold the policy before a condition you had at purchase becomes claimable. Capped at a maximum of 36 months under the 2024 Master Circular, down from the earlier 48-month ceiling — many insurers offer shorter. |
| Moratorium period | After 60 months (5 years) of continuous coverage — cut from the earlier 96 months (8 years) — an insurer can no longer contest a claim or the policy itself for non-disclosure or misrepresentation, except in cases of proven fraud. This is the single biggest tilt toward policyholders in the 2024 reforms, but it protects against non-disclosure disputes specifically — it does not override a standing permanent exclusion, an active sub-limit, or a co-pay. |
| Restoration / refill benefit | Automatically reinstates the sum insured (often once per year, sometimes only for an unrelated illness) after it is exhausted by a claim — valuable for families with more than one member who could be hospitalised in the same year. |
| No-claim bonus (NCB) | A cumulative increase in sum insured (or, less commonly, a premium discount) for each claim-free year, usually capped at 50–100% of the base sum insured over time. Fully portable if you switch insurers correctly. |
| Pre- and post-hospitalisation cover | Diagnostic and consultation expenses in a defined window (commonly 30–60 days before admission and 60–90 days after discharge) even though you weren't admitted on those dates. |
| Day-care procedures | Treatments that once required overnight stays but no longer do (cataract surgery, many chemotherapy cycles, some scopes) are covered without the usual 24-hour minimum-stay condition — check the insurer's specific day-care list, since it varies. |
04 The 2024–2026 Regulatory Reset: What Actually Changed, and When
Health insurance regulation in India has moved more in the past two years than in the previous decade. This matters for the blog’s own credibility test: a great deal of content circulating online — including from insurers themselves — still describes an 8-year moratorium, an 18% GST line, or room-rent deductions that eat into medicine and diagnostic costs. All three are now out of date. Below is what is actually in force, each traceable to a specific, dated regulatory action, followed by what remains proposed rather than notified.
| Change | Effective date | What it means |
|---|---|---|
| IRDAI Master Circular on Health Insurance Business | 29 May 2024 | Consolidated 55 earlier circulars into one rulebook. Introduced the 60-month moratorium, the 36-month PED waiting-period cap, removed maximum entry-age limits, and mandated a 1-hour cashless pre-authorisation decision and a 3-hour final discharge authorisation. |
| Free-look period extended | For policies issued on or after 1 April 2024 | Extended from 15 days to 30 days — the window in which a new policy can be returned for a full refund if the terms don't match what was represented at sale. |
| ‘Cashless Everywhere’ initiative | 23–25 January 2024 | A General Insurance Council initiative (not itself a binding IRDAI regulation, though it aligns with the regulator's stated direction) under which insurers are expected to offer cashless treatment at any registered hospital, not only their empanelled network — subject to the treatment being admissible and the hospital cooperating on documentation |
| Commission deregulation — EOM Regulations | 1 April 2024 (building on 2023 reforms) | Product-wise commission caps were removed in 2023; insurers now manage commission within an overall Expenses of Management ceiling — 35% of gross written premium for standalone health insurers, 30% for general insurers. This gives insurers latitude to pay far higher commission on some products than others, which is a direct structural driver of steering and mis-selling (see Section 6). |
| GST exemption on individual health premiums | 22 September 2025 | The 56th GST Council removed 18% GST on individual life and health premiums entirely, including family floater and senior-citizen plans. Group and employer-sponsored policies remain taxed at 18%. |
| Ayushman Vay Vandana Yojana | 29 October 2024 | Extended AB PM-JAY-linked cover of ₹5 lakh/year to every citizen aged 70+, regardless of income, on top of any existing family PM-JAY entitlement — with no waiting period, even for pre-existing conditions. |
| Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025 | Passed by Parliament 16–17 December 2025; commencement notified 5 February 2026 | The most significant insurance-law overhaul since liberalisation in 2000. Raises the FDI cap in Indian insurers from 74% to 100% under the automatic route, ending the requirement for a domestic joint-venture partner. Separately — and more directly relevant to this guide — it raises the maximum penalty IRDAI can levy for regulatory violations from ₹1 crore to ₹10 crore, extends IRDAI's inspection and investigation powers to intermediaries (agents, brokers, corporate agents, TPAs), and for the first time gives IRDAI express statutory power to cap and regulate commission, remuneration and rewards paid to agents and intermediaries — the exact lever Section 6 of this guide identifies as the structural driver of steering and mis-selling. It also establishes a dedicated Policyholders' Education and Protection Fund. |
| Bima Sugam — phased go-live | Motor insurance (new vehicles) from June 2026; health insurance listings following from August 2026; term/life insurance targeted for September 2026 | IRDAI's zero-commission digital marketplace — insurers pay a platform fee of roughly 5–7% instead of traditional commission — moved from repeatedly-delayed proposal to an actual phased rollout in mid-2026, after missing every earlier target date since January 2023. Health insurance listings are the newest phase as of this guide's writing; treat the depth of product choice and real consumer adoption on the health side as still maturing rather than fully proven. |
A GST nuance worth knowing before you assume the full 18% flowed through
The GST exemption removes the tax line, but insurers also lose the input tax credit they previously claimed on their own costs when the output was taxed. Several analyses — including one from HSBC — estimated the net premium saving passed on to policyholders at closer to 15% than a full 18%, once insurers repriced to recover the lost credit. Check your actual renewal invoice rather than assuming an automatic 18% cut; the regulator’s anti-profiteering mechanism is meant to police this, but variance across insurers has been reported.
What is still directional rather than fully settled
- Specific new commission caps under the 2025 Act’s expanded powers — IRDAI’s current chairman, Ajay Seth (in office since 1 September 2025), has publicly flagged a shift toward “effort-based” commission that rewards servicing and retention over front-loaded first-year payouts. The Sabka Bima Sabki Raksha Act now gives IRDAI the statutory power to actually set such limits; as of writing, the power exists but specific revised commission regulations under it have not yet been notified. Watch this space — it would meaningfully blunt the steering incentive described in Section 6 if it lands as flagged.
- Bima Sugam’s health-insurance depth and consumer adoption. The platform itself is now live in phases rather than merely proposed, but a newly launched marketplace and a mature, trusted one are different things — how many insurers list competitively priced health products on it, and how many buyers actually use it over an aggregator or agent, will only be clear over the coming renewal cycles.
05 Ten Misconceptions That Quietly Cost Indian Families Money
“My employer’s group health cover is enough, I don’t need my own policy.”
Group cover ends the day you resign, are laid off, or retire — typically with no continuity guarantee to an individual plan, and often no medical test-free conversion option. It also usually carries a lower per-hospitalisation sum insured than families assume, is not portable in the same way individual policies are, and can be reduced or altered by the employer’s own annual renewal negotiation without much notice to employees. Treat it as a supplement to a personally owned base policy, never as the whole plan — especially past your mid-40s, when buying fresh individual cover for the first time gets harder and more expensive.
“A pre-existing condition means I can never claim for it.”
A pre-existing disease is covered after the waiting period runs out — now capped at a maximum of 36 months under the 2024 Master Circular, and often shorter with individual insurers. It is a delay, not a permanent exclusion, except for the specific short list of conditions an insurer is permitted to exclude permanently under IRDAI’s 2020 standardisation guidelines, which must be named explicitly in the policy schedule.
“Cashless Everywhere means cashless treatment is now guaranteed anywhere, always.”
Cashless Everywhere, launched by the General Insurance Council in January 2024, means insurers are expected to arrange cashless settlement even at non-network hospitals, provided the claim is admissible and the hospital cooperates with the insurer’s documentation and TPA process. In practice, hospitals with no prior relationship to your insurer sometimes still push reimbursement, especially for emergency admissions where pre-authorisation timelines are tight. It materially improved a real problem — roughly 4 in 10 claims historically went the slower reimbursement route purely because of network mismatch — but ‘everywhere, no exceptions’ oversells it.
“The cheapest premium for the same sum insured is the best deal.”
Two ₹10 lakh policies at similar premiums can differ enormously in room rent caps, disease-wise sub-limits, co-pay, the permanently excluded conditions list, and network hospital breadth. The premium is one line item in a much longer comparison; a policy that is 15% cheaper but caps room rent at ₹3,000/day in a metro, or carries a mandatory 20% co-pay after 60, is very likely to cost far more than the saving at the one moment it matters.
“A high claim settlement ratio (CSR) means this insurer pays claims fully and fairly.”
IRDAI’s own chairman flagged this directly in late 2025: CSR counts how many claims were approved, not what fraction of the billed amount was actually paid. An insurer can show a 95%+ CSR while routinely settling 60–70% of the actual bill through room-rent proportionate deductions, disease sub-limits, and non-payable items. Use CSR as one screen, then separately check the incurred claim ratio (the share of premium income paid out as claims — a healthy range is roughly 70–90%) and, where you can find it, average settlement-to-bill ratio or complaint volume.
“Once I renew for a few years without a claim, my premium won’t rise much.”
Health insurance premiums are repriced based on the insurer’s overall claims experience across its entire portfolio and rising medical inflation industry-wide, not primarily your individual claim history (unlike motor insurance’s no-claim bonus logic). A claim-free individual can still see a renewal premium jump of 15–25% or more at a portfolio-wide repricing, particularly on older-generation products insurers are trying to phase out.
“All hospitals are covered under any policy I buy.”
Cashless facility is contractual and depends on network tie-ups (materially widened, not made universal, by Cashless Everywhere); reimbursement is possible at any registered hospital but requires you to pay upfront and claim later. Check your specific insurer’s network list for the hospitals you’d actually use — particularly for a senior parent whose preferred hospital may not carry a large TPA relationship.
“I’m healthy, I’ll buy health insurance later when I actually need it.”
Waiting periods, PED clauses, and underwriting all run from the date you buy — not from the date you fall ill. Buying young and healthy locks in a lower premium, starts the PED and moratorium clocks running while you have nothing to disclose, and avoids the real risk of a diagnosis making you uninsurable, or insurable only with permanent exclusions and loading, exactly when you’d want cover most.
“A rider on my life insurance policy is basically the same as a standalone health policy.”
Health riders on life insurance policies are typically benefit-based (a fixed payout on a listed critical illness) rather than indemnity-based (reimbursing actual hospital bills up to a sum insured), often carry a smaller effective sum insured, and are usually far less comprehensive on hospitalisation, day-care, and pre/post-hospitalisation cover. Useful as a supplementary layer, not a substitute for a dedicated health policy.
“Government schemes like Ayushman Bharat mean private cover is now optional for everyone.”
AB PM-JAY and the Ayushman Vay Vandana Yojana are genuinely valuable and every eligible family, including affluent ones with a parent turning 70, should register — it costs nothing and stacks with private cover. But ₹5 lakh a year against 12–14% medical inflation, largely at government and mid-tier private hospitals, is a floor for a family used to metro tertiary care, not a ceiling.
06 How Mis-Selling Actually Works — The Mechanics, Not Just the Complaint
“Mis-selling” is often described as if it’s simply agent dishonesty. Some of it is. But a meaningful share of it is structural — built into how commission, product design, and sales incentives are currently regulated — which is why understanding the mechanism helps you spot it in real time, not just complain about it afterward.
The commission structure creates a steering incentive, not just a service one
Since the 2023–2024 reforms, IRDAI no longer caps commission product-by-product; insurers manage total commission spend within an overall Expenses of Management ceiling (35% of gross written premium for standalone health insurers). This gives an insurer latitude to pay a much richer commission on one product than another — typically higher on newer, harder-to-sell, or add-on-heavy products — within the same overall envelope. An agent facing two products that both suit a customer reasonably well has a direct financial reason to steer toward the higher-commission one. This is legal. It is also, functionally, a mis-selling mechanism, because the steering is invisible to the buyer, who has no way to see what commission differential is driving the recommendation.
Bundling and forced riders
A common pattern, especially through bank branch (bancassurance) channels, is presenting a health policy with pre-selected riders — personal accident, critical illness top-up, hospital cash — bundled into a single quoted premium, without clearly separating what the base product costs versus what each add-on costs. The buyer is shown one number and one signature line, not a menu. Always ask explicitly: “what is the premium for the base policy alone, with every rider stripped out?” If that number isn’t readily produced, that itself is a signal.
Churn: selling a new policy instead of recommending portability
Because first-year commission on a new policy is typically far higher than renewal commission on an existing one, an agent has a direct incentive to persuade a dissatisfied policyholder to buy a fresh policy with a different insurer — losing accumulated no-claim bonus, restarting underwriting, and in the worst cases resetting the moratorium clock — rather than the equally available, benefit-preserving option of porting the existing policy to a new insurer at renewal (see Section 4’s portability mechanics). Porting is free, IRDAI-mandated, and preserves earned continuity benefits up to your existing sum insured; a fresh policy sale earns the agent more. If an agent recommends starting over rather than porting, ask them directly why porting isn’t the better option — a good agent has a real answer; one relying on the higher commission usually doesn’t.
Targeting seniors with unsuitable underwriting-light products
Products marketed as “no medical test required” are attractive to seniors who fear being declined, but they typically carry materially higher premiums, mandatory co-pay, and shorter but real PED waiting periods to compensate the insurer for weaker underwriting information. Sold without that trade-off being explained, a senior can end up paying a premium priced for undisclosed risk while still facing a co-pay and a waiting period they weren’t told to expect.
Misrepresenting waiting periods and permanent exclusions at the point of sale
The single most common grievance pattern in IRDAI’s own complaint data is a claim denied for a condition the buyer was told, verbally, would be covered — when the written policy schedule said otherwise. The written Customer Information Sheet (a standardised, plain-language summary IRDAI now mandates every insurer provide) is the only document that matters at claim time; a verbal assurance from an agent has no standing against it. Read the CIS before signing, not after a claim is denied.
“If I strip out every rider and just take the base policy, what’s the premium, and how does your recommendation compare to porting my existing policy instead of replacing it?” An agent who answers both parts clearly and immediately is very likely acting in your interest. An agent who deflects, bundles the answer back into a single number, or discourages you from even considering portability is showing you the commission incentive at work — not giving you advice.
07 The Online and Digital Shift: What's Actually Changing
Distribution is moving from a relationship-driven, agent-led model toward a transparency-driven, comparison-led one — unevenly, and with real gaps that are worth knowing before assuming a portal or app has solved the problem.
Aggregators and web-aggregators
Licensed insurance brokers and web-aggregators let you compare multiple insurers’ products, premiums, and (where disclosed) claim settlement data side by side, and typically earn commission from the insurer rather than charging the buyer directly. This is genuinely useful for narrowing a shortlist — but the same commission-driven steering risk from Section 6 applies to online recommendations as much as to an in-person agent; a portal’s “top recommended” badge is not independent of what it earns on each product.
Bima Sugam — the promised marketplace, now actually arriving in phases
IRDAI’s own not-for-profit digital marketplace, run by the Bima Sugam India Federation, lets policyholders compare, buy, port, and manage claims across participating insurers from a single government-anchored platform, at a materially lower platform fee (roughly 5–7% of premium, paid by the insurer, versus the higher effective cost of commission-driven private aggregators) — a genuinely zero-commission model for the buyer. After missing nearly every target date since it was first proposed in January 2023, the platform began an actual phased go-live in mid-2026: motor insurance for new vehicles first, from June 2026, with health insurance listings joining from August 2026 and term life insurance targeted for September 2026. This is a real, structural change to distribution economics, not merely a delayed promise anymore — but a newly launched marketplace and a mature one are different things. How deep and competitively priced the health insurance product listings actually are, and how many buyers use the platform over a familiar aggregator or agent, will only become clear over the next few renewal cycles. Worth checking before your next purchase, not yet worth assuming has replaced every other channel.
The National Health Claims Exchange (NHCX)
A separate, more quietly significant piece of digital infrastructure: IRDAI’s push to standardise and digitise claim submission between hospitals, insurers, and TPAs, reducing the paperwork-driven delay and error that cause many claim disputes. Adoption has been building steadily since 2024 and is one of the more concrete drivers behind the 1-hour and 3-hour cashless timelines actually being achievable in practice, since a manual, fax-and-courier claims process simply cannot meet them.
What digital buying genuinely improves — and what it doesn’t
- Improves: side-by-side comparison of stated terms, faster e-KYC and policy issuance, a documented digital trail of what was disclosed and quoted (useful evidence if a claim dispute arises later).
- Doesn’t automatically improve: the underlying commission-driven steering, the reading and understanding of policy wording (the CIS still has to actually be read), or underwriting quality for complex medical histories, which often still benefits from a knowledgeable human intermediary — ideally a fee-based advisor rather than a commission-earning one.
08 Getting Cost and Coverage Right: A Practical Framework
Two decisions dominate whether a policy actually protects a family’s wealth: how much sum insured is enough, and how to read insurer quality signals correctly rather than being misled by headline marketing numbers.
Sizing the sum insured against medical inflation, not against what feels like “a lot”
A ₹5 lakh sum insured that felt generous a decade ago is, at a sustained 12–14% medical inflation trend, worth roughly a third of that in real treatment-purchasing-power terms today. For a metro-based family, ₹25–50 lakh of effective cover (base policy plus super top-up) is now a more realistic working target than the ₹5–10 lakh figure many households still default to; smaller cities can reasonably target somewhat lower given generally lower treatment costs, though the gap is narrowing as private hospital chains expand into tier-2 cities. Re-evaluate the adequacy of a sum insured at every renewal, not just when a shortfall is discovered during a hospitalisation.
Reading claim quality signals correctly
- Claim settlement ratio (CSR): what fraction of claims were approved. Screening tool only — does not tell you how much of the bill was actually paid (see Section 5).
- Incurred claim ratio (ICR): the share of premium income an insurer pays out in claims. A healthy range is roughly 70–90%; a figure persistently above 100% raises questions about the insurer’s long-term pricing sustainability and future premium hikes; a figure well below 70% can indicate aggressive claim restriction, though it can equally reflect tighter underwriting and a healthier risk pool — context matters more than the number alone. IRDAI’s Annual Report 2024–25 showed real variation by insurer category: public sector insurers around 97%, private general insurers’ health segment around 77–78%, and standalone health insurers (SAHIs) — insurers that write only health business — notably lower, at roughly 68%. Don’t conflate the last two categories: a “private insurer” figure quoted without specifying general insurer versus standalone health insurer is not comparing like with like. Check the specific figure for the specific insurer, and specific product category, you’re evaluating.
- Grievance and complaint volume: available via IRDAI’s Bima Bharosa system and the Annual Report’s grievance classification tables — a heavier, harder-to-find signal than CSR, but a more honest one.
- Network hospital depth in your actual city: a large national network number is meaningless if the hospitals you’d realistically use aren’t on it — check by name, not by count.
Family floater versus separate policies — the arithmetic that decides it
As a rule of thumb, a family floater remains efficient while every covered member is broadly similar in age and risk. Once a parent above roughly 55–60 is added to a floater with young children, the pooled premium is usually pushed up disproportionately by the older member’s risk, while the older member’s own effective protection is diluted by sharing the sum insured with everyone else in the family. At that point, splitting into a floater for the younger members plus a dedicated senior citizen policy for the parent, sized and underwritten on the parent’s own risk, is very often the better-value structure — even though it looks like ‘two policies’ rather than the administratively simpler ‘one policy.’
If you hold a PPF account and became non-resident at any point, write to your bank or post office and get your account’s current interest status confirmed in writing. An account sitting at zero percent while you continue to deposit into it is the worst outcome available, and it will not announce itself on your passbook. Note that the treatment turns on which version of the scheme your account was opened under and what Form H recorded at the time. This is account-specific — verify yours rather than relying on a general article, including this one.
Match the instrument to the deadline, not to your personality. Money you will need within five years does not belong in equity, however young and risk-tolerant you are. Money you will not touch for fifteen years does not belong entirely in PPF, however cautious you are. The horizon decides — and if you are on the new tax regime, decide it knowing that PPF no longer comes with a deduction attached.
09 Special Considerations: Senior Citizens and Retirees
Seniors are simultaneously the group that benefits most from health insurance and the group most exposed to mis-selling, because underwriting genuinely gets harder and pricier with age — which is exactly the gap unsuitable products are marketed into.
What actually changed for seniors in 2024
- No maximum entry age: insurers can no longer categorically refuse a health insurance application solely on the grounds of age, though premiums and underwriting terms will reflect the higher risk.
- The 60-month moratorium and 36-month PED waiting-period cap apply to senior policies exactly as they do to any other indemnity health policy.
- Ayushman Vay Vandana Yojana provides a further ₹5 lakh/year, income-blind, to every citizen 70+, stacking with private cover — register regardless of what private policy a parent already holds. It’s also worth registering as a genuine backup floor for exactly the situation private cover handles worst: unlike a private policy’s PED waiting period of up to 36 months, the Ayushman Vay Vandana Card covers pre-existing conditions from day one, with no medical check-up required. For a parent with an already-diagnosed chronic condition a private insurer would exclude or delay covering, this is not a lesser option — it may be the only cover paying from month one.
What to check specifically before buying a senior citizen policy
- Co-pay: very common on senior products (commonly 10–30%) and easy to miss when the premium looks attractive — it applies to every claim, not just large ones.
- Pre-policy medical check-up requirements: policies requiring a check-up generally underwrite more accurately and price more fairly for an individual’s actual risk than “no test required” products, which price for the average undisclosed risk across the whole pool — often at the healthy applicant’s expense.
- Disease-specific sub-limits: cataract, joint replacement, and cardiac procedure sub-limits are disproportionately relevant to this age group — check them by rupee amount, not just by whether the condition is “covered.”
- Restoration benefit: particularly valuable where a couple shares a floater, since it reduces the risk of one hospitalisation exhausting the year’s cover for the other spouse.
- Domiciliary and home healthcare cover: increasingly relevant for age-related chronic conditions managed at home rather than through hospitalisation — check whether it’s included or a separate rider.
10 Special Considerations: NRIs and Overseas-Managed Cover for India
NRIs, OCI cardholders and PIOs face a distinct set of questions — not because the underlying products differ, but because eligibility, premium payment routing, and coverage scope have India-specific rules that a domestic buyer never has to think about.
Eligibility and what’s covered
NRIs, OCIs and PIOs are eligible to buy the same standard Indian health insurance products residents buy — there is generally no separate “NRI-only” product line, whatever some marketing suggests. The critical scope limitation: domestic Indian health policies cover treatment received within India only. Medical expenses incurred abroad are not covered unless the plan specifically carries an international or global add-on, which is uncommon on standard retail products. For an NRI managing cover for parents resident in India, or buying cover for their own use during visits, this is exactly the right product category; for cover while actually living abroad, a separate international health plan is needed.
Premium payment and the GST exemption
Premiums are paid in Indian rupees, typically from an NRE or NRO account, or via Indian debit/credit cards, UPI, or net banking during a visit. Because NRIs, OCIs and PIOs buying individual (non-group) policies fall under the same “individual” categorisation the 56th GST Council used for the September 2025 exemption, the 0% GST rate applies to NRI-purchased individual and family floater policies on the same terms as resident purchases — confirm this explicitly with the insurer at purchase, since some NRI-facing sales channels have been slower to update quoted premiums than domestic retail channels.
Residency status, disclosure, and continuity
- KYC: expect to provide a passport, PAN or Form 60, OCI card where applicable, both Indian and overseas address proof, and insurer-specific NRI or FATCA residency declarations — requirements vary meaningfully by insurer, so confirm the specific document list before starting an application.
- Medical underwriting from abroad: tele-medical assessment or lab tests arranged locally overseas are common for age or sum-insured thresholds that would otherwise require an in-person check-up; a physical examination, if required, is usually scheduled for the next India visit.
- Notify on status change: update the insurer if residency status changes — returning to India permanently, for instance — since this can affect underwriting and future renewal terms; earned continuity benefits (waiting period credit, no-claim bonus) carry through the change if disclosed properly.
- Buy before returning, not after: for NRIs planning a return to India, the waiting-period and moratorium clocks only start running from the date a policy is issued — buying a domestic policy while still abroad and healthy, rather than waiting until after the move, starts continuity benefits accruing earlier and avoids underwriting a fresh policy immediately after a major life transition.
Two structural choices matter more than the specific insurer: buy a dedicated senior citizen policy for the parent rather than adding them to a distant floater you don’t hold, since claim coordination is far simpler when the parent is themselves the primary insured and can act locally; and register parents above 70 for the Ayushman Vay Vandana card regardless of their private cover — it’s free, income-blind, and gives a second cashless option if the private insurer’s network doesn’t reach a hospital near them.
11 A Step-by-Step Framework for Choosing the Right Policy
1
Size the need before shopping for products
Estimate a realistic sum insured against current metro or tier-2 treatment costs and 12–14% medical inflation, not against what your current policy already provides. Decide whether a family floater, an individual policy, or a base-plus-super-top-up structure fits your family’s age spread
2
Shortlist on written terms, not verbal pitches
Pull the Customer Information Sheet for each candidate policy and compare, side by side: room rent limit and proportionate deduction scope, PED waiting period, disease-wise sub-limits, co-pay, permanent exclusions, and restoration benefit. Price is one column among many, not the sorting key.
3
Check claim quality signals beyond CSR
Look up incurred claim ratio and, where available, grievance volume via IRDAI’s Bima Bharosa data and the latest IRDAI Annual Report, rather than relying solely on an insurer’s or aggregator’s advertised claim settlement ratio.
4
Verify the network for hospitals you’d actually use
Search the insurer’s current network list by the specific hospital names relevant to your family and city — not the aggregate network size — and confirm cashless availability specifically, since reimbursement-only status at a preferred hospital changes the real value of a policy considerably.
5
Ask the base-premium-versus-riders question directly
Before signing, get a clean quote for the base policy with every rider stripped out, and a separate line for each add-on. Decline any bundle you can’t get itemised.
6
Disclose fully, in writing
Complete the proposal form’s medical history section accurately and completely — non-disclosure is the single most common ground for claim repudiation before the moratorium runs, and the written proposal form, not a verbal conversation with an agent, is what an insurer relies on at claim time.
7
Use the 30-day free-look period actively
Read the issued policy document — not just the sales brochure — within the 30-day free-look window and cancel for a full refund if the terms don’t match what was represented at sale.
8
Reassess at every renewal, not just at first purchase
Revisit sum-insured adequacy against current treatment costs, check whether a better-value port is available (starting the process at least 45 days before renewal), and confirm no undisclosed changes have crept into the renewed terms.
12 Red Flags: How to Recognise Mis-Selling in the Moment
None of these alone proves bad intent — but any of them is a reason to slow down, ask direct questions, and get answers in writing before signing.
⚠ A single bundled premium quote that won’t break down into base policy plus individual riders when asked.
⚠ Pressure to decide within the meeting, or a claim that a price or offer expires that same day.
⚠ A recommendation to buy a new policy with a different insurer rather than port an existing one, without a clear, specific reason tied to your coverage needs.
⚠ Verbal assurance that something is covered which isn’t confirmed in the written Customer Information Sheet or policy schedule.
⚠ Reluctance to provide the policy wording, exclusions list, or network hospital list before you commit to buying.
⚠ A “no medical test required” pitch to a senior citizen with no mention of the co-pay or premium loading that typically comes with it.
⚠ Being steered away from asking about the free-look period, or being told it doesn’t apply.
⚠ An agent who cannot clearly explain the difference between claim settlement ratio and incurred claim ratio when asked.
Never evaluate a health insurance policy on premium and headline sum insured alone. Read the Customer Information Sheet before you sign, not after you claim — because the written policy schedule, not any verbal promise made at the point of sale, is the only document an insurer will honour at the hospital bed.
Key Takeaway
India’s health insurance regulation has genuinely tilted toward policyholders since 2024 — a shorter moratorium, a capped PED waiting period, no GST on individual premiums, wider cashless access, and no maximum entry age. None of that protects a family that hasn’t sized its cover to actual medical inflation, hasn’t read the written terms before signing, or has been steered by commission rather than fit. The regulatory tailwind makes buying and holding the right policy easier than it was two years ago — it does not do the reading and comparing for you.
Quick-Reference: Where to Go for Help
| Need | Contact |
|---|---|
| IRDAI grievance registration (Bima Bharosa) | bimabharosa.irdai.gov.in · Toll-free 155255 / 1800-4254-732 · complaints@irdai.gov.in |
| Insurance Ombudsman (free, binding, disputes up to ₹50 lakh; use after 30 days with no insurer resolution) | cioins.co.in — 17 regional offices across India |
| Ayushman Bharat PM-JAY eligibility, empanelled hospitals, general queries | Toll-free 14555 |
| Ayushman Vay Vandana Card (age 70+) specific queries | Toll-free 1800-11-0770 |
| National Health Authority general helpline | Toll-free 1800-11-4477 |
